Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has completed a significant capital injection of RMB493.6 million into Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd. This move, involving the transfer of full equity interest in Tianjin Zhongxin Medicine Co., Ltd., aims to strengthen its position in the pharmaceutical sector. The completion follows the resolutions passed during the company’s board meeting and subsequent approvals.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.